共 32 条
[1]
BARR WH, 1984, PHARMACOTHERAPY, V4, P167
[2]
COMPARISON OF STANDARD-RELEASE AND SUSTAINED-RELEASE THEOPHYLLINE TABLETS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1979, 36 (05)
:613-617
[5]
FREQUENT TOXICITY FROM IV AMINOPHYLLINE INFUSIONS IN CRITICALLY ILL PATIENTS
[J].
DRUG INTELLIGENCE & CLINICAL PHARMACY,
1977, 11 (01)
:12-18
[6]
ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1977, 34 (05)
:525-527
[7]
HENDELES L, 1983, PHARMACOTHERAPY, V3, P2
[8]
CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1976, 235 (18)
:1983-1986
[10]
KARIM A, 1984, 3RD ANN C CURR CONC